To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Evotec Completes Acquisition of Kinaxo Biotechnologies GmbH
Evotec AG announced that it has completed the acquisition of Kinaxo Biotechnologies GmbH, a privately held drug discovery alliance company supporting the development of targeted drugs. As a result of the transaction, first announced on February 9, 2011, Kinaxo has become a wholly-owned subsidiary of more
KINAXO Announces European Patent Granted for its Chemical Proteomics Applications
KINAXO Biotechnologies GmbH announced that the European Patent Office has granted a patent entitled “Proteome-wide quantification of small molecule binding to cellular target proteins” (EP2045332B1). The patent covers technologies exclusively marketed by KINAXO under the trademarks Cellular Target P more
KINAXO Extends Collaboration with Takeda
KINAXO Biotechnologies GmbH announced that it has entered a second collaboration with Takeda Pharmaceutical Company Limited Osaka, Japan. Under the agreement KINAXO will apply its quantitative phosphoproteomics technology PhosphoScout® to assist in research of drugs under development at Takeda. This more
HOME ABOUT US TECHNOLOGY SERVICES PUBLICATIONS FAQ CONTACT KINAXO Team Advisory Board Scientific Advisors Investors Careers KINAXO Cellular Target Profiling ® KinAffinity ® PhosphoScout ® Scientific Papers Press Releases Application Notes Technical Notes Fact Sheet (PDF more
KINAXO announces agreement with UCB Martinsried, Germany, November 6, 2006. KINAXO Biotechnologies GmbH announced today that it has entered into a services and collaboration agreement with UCB S.A. of Brussels, Belgium (UCB). Under the agreement, KINAXO will employ the KinaTorTM technolog more